Drugs are essential for preventing and treating diseases. Before a “drug” can become available to many patients, a “drug candidate” discovered through research must be evaluated for efficacy and side effects (safety) to gain approval as a “drug” from the government (Ministry of Health, Labour and Welfare).
The first step involves evaluating the efficacy, safety and other attributes of drug candidates using animal models and other methods. Then, we assess the efficacy and side effects in detail through cooperation with healthy subjects and patients who meet specific criteria. This study is called a clinical trial. Clinical trials are a necessary part of developing a new drug.
For more information about clinical trials, please visit the following links (Japanese Site):
Drugs are essential for preventing and treating diseases. Before a “drug” can become available to many patients, a “drug candidate” discovered through research must be evaluated for efficacy and side effects (safety) to gain approval as a “drug” from the government (Ministry of Health, Labour and Welfare).
The first step involves evaluating the efficacy, safety and other attributes of drug candidates using animal models and other methods. Then, we assess the efficacy and side effects in detail through cooperation with healthy subjects and patients who meet specific criteria. This study is called a clinical trial. Clinical trials are a necessary part of developing a new drug.
For more information about clinical trials, please visit the following links (Japanese Site):
Taisho Pharmaceutical is committed to increasing our transparency regarding clinical trial information.
We recognize that properly disclosing outlines of our clinical trials in a timely manner, in accordance with national laws, regulations and guidelines on the disclosure of clinical trial information by pharmaceutical companies, will contribute to the advancement of science and medicine, improve people’s health and aid in the progress of pharmaceutical development.
Taisho Pharmaceutical is committed to increasing our transparency regarding clinical trial information.
We recognize that properly disclosing outlines of our clinical trials in a timely manner, in accordance with national laws, regulations and guidelines on the disclosure of clinical trial information by pharmaceutical companies, will contribute to the advancement of science and medicine, improve people’s health and aid in the progress of pharmaceutical development.
Taisho registers and discloses outlines of clinical trials on publicly accessible registry websites. These clinical trial registry websites provide the public and medical staff with adequate information. Registered information includes protocols, target diseases, enrollment status, results, and more.
Click the following links to view the clinical trial registry websites.
System for submitting and disclosing clinical research (jRCT, Japan Registry of Clinical Trials)
ClinicalTrials.gov (Database of clinical trials in the United States)
Taisho registers and discloses outlines of clinical trials on publicly accessible registry websites. These clinical trial registry websites provide the public and medical staff with adequate information. Registered information includes protocols, target diseases, enrollment status, results, and more.
Click the following links to view the clinical trial registry websites.
System for submitting and disclosing clinical research (jRCT, Japan Registry of Clinical Trials)
ClinicalTrials.gov (Database of clinical trials in the United States)
Taisho will appropriately publish the medical important results of clinical trials at conferences and journals, . When a paper is published, it is registered with publicity accessible clinical trial registry websites. A summary of the clinical trial results based on the clinical study report is also registered on the Japan Registry of Clinical Trials.
Taisho will appropriately publish the medical important results of clinical trials at conferences and journals, . When a paper is published, it is registered with publicity accessible clinical trial registry websites. A summary of the clinical trial results based on the clinical study report is also registered on the Japan Registry of Clinical Trials.
Please agree to the Terms of Use and click the button below.
Please agree to the Terms of Use and click the button below.
The next webpage is designed to share information about clinical trials with those who search it.
Please read the Terms of Use before viewing the webpage.
The next webpage is designed to share information about clinical trials with those who search it.
Please read the Terms of Use before viewing the webpage.
【Terms of Use】
【Terms of Use】
Do you agree to the Terms of Use above?
Do you agree to the Terms of Use above?
Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd.